Pulmonary hypertension is a common complication of COPD, but CT scanning and lung function tests do not identify patients at risk

A. M. Higton, C. A. Benjamin-Smith, E. C. Floyd, R. G. Harvey, E. H. Baker (London, United Kingdom)

Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Session: COPD: phenotyping and monitoring
Session type: Thematic Poster Session
Number: 1311
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. M. Higton, C. A. Benjamin-Smith, E. C. Floyd, R. G. Harvey, E. H. Baker (London, United Kingdom). Pulmonary hypertension is a common complication of COPD, but CT scanning and lung function tests do not identify patients at risk. Eur Respir J 2010; 36: Suppl. 54, 1311

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension in COPD: results from the ASPIRE registry
Source: Eur Respir J 2013; 41: 1292-1301
Year: 2013



CT predictors of pulmonary hypertension in patients with severe COPD
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018



Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021
Year: 2022



Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

The acute effect of budesonide/formoterol in COPD: a multi-slice computed tomography and lung function study
Source: Eur Respir J 2012; 40: 298-305
Year: 2012



Correlation of CT estimated lung volumes with pulmonary function tests in COPD patients
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006


Factors influencing the decline in lung density in a Danish lung cancer screening cohort
Source: Eur Respir J 2012; 40: 1142-1148
Year: 2012



Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry
Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021
Year: 2021



Volumetric CT emphysema quantification for predicting pulmonary hypertension in patients with moderate to severe stable COPD
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010

The extent of emphysema in patients with COPD
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006


Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

HRCT imaging of lung parenchyma in chronic heart failure (CHF) patients: correlation with pulmonary function tests
Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations
Year: 2008

The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Pulmonary functional tests in patients with severe COPD after lung volume reduction surgery
Source: Eur Respir J 2002; 20: Suppl. 38, 606s
Year: 2002

Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Lung cancer in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 1216-1219
Year: 2001



Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Pulmonary disease in primary Sjögren´s syndrome: symptoms, pulmonary function tests and HRCT
Source: Eur Respir J 2004; 24: Suppl. 48, 487s
Year: 2004

Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018